[A national survey from the French Society of Pathology on research and application of artificial intelligence in pathology].

Journal: Annales de pathologie
PMID:

Abstract

The 2030 French Innovation Healthcare national plan defined "Digital Healthcare" as one of its priority. The deployment of digital pathology and artificial intelligence fits perfectly into this framework. Therefore we evaluated the pathologist's interest in those fields by conducting an online survey among members of the French Society of Pathology, mainly composed of senior pathologists and trainees (n=2301). We collected 123 answers originating nationwide and representative of all status of practice. A heavy majority of participants (83%) declared themselves "interested or very interested" in digital transition and AI. Twenty-six percent of participants took part in academic research projects and 20% in industrial research projects. With digital pathology becoming increasingly common nationwide, there is a growing interest of pathologists in the development and validation of AI algorithms. In order to support this dynamic, a commission for research on artificial intelligence has been created under the authority of the French Society of Pathology.

Authors

  • Pierre Allaume
    Service d'anatomie et cytologie pathologique, hôpital Pontchaillou, CHU de Rennes, université de Rennes 1, 2, rue Henri-Le-Guilloux, 35033 Rennes cedex, France. Electronic address: pierre.allaume@chu-rennes.fr.
  • Raphaël Bourgade
    Department of Pathology, University Hospital of Nantes, Nantes, France. Electronic address: raphael.bourgade@gmail.com.
  • Arnaud Uguen
    CHRU Brest, Department of Pathology, Brest, 29220, France.
  • Thierry Pécot
    Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, 29407, USA.
  • Sophie Prevot
    Pathologie, CHU Bicêtre, AP-HP, 78, rue du Général Leclerc, 94270 Le Kremlin-Bicêtre, France.
  • Catherine Guettier
    Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.
  • Janick Selves
    Department of Pathology, Purpan Hospital, CHU Toulouse, France.
  • Philippe Bertheau
    Pathologie, CHU Saint-Louis, AP-HP, et université de Paris, 1, avenue Claude Vellefaux, 75010 Paris, France. Electronic address: philippe.bertheau@gmail.com.
  • Camille Franchet
    Department of Pathology, University Cancer Institute of Toulouse-Oncopole, Toulouse, France.
  • Magali Svrcek
    Dpt of Pathology, Saint-Antoine Hospital - Sorbonne Universités, Paris, France.
  • Jean-Christophe Sabourin
    Service d'anatomie et cytologie pathologique, CHU de Rouen, 1, rue de Germont, 76031 Rouen cedex, France.
  • Marie Brevet
    MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; Hospices Civils, East Hospital Group, Department of Pathology, Lyon, France.
  • Julien Calderaro
    Department of Pathology, Henri Mondor University Hospital, Créteil, France.
  • Nathalie Rioux-Leclercq
    Department of Pathology, Rennes University Hospital, Rennes, France.
  • Delphine Loussouarn
    Department of Pathology, University Hospital of Nantes, Nantes, France.
  • Solène-Florence Kammerer-Jacquet
    Department of Pathology, Rennes University Hospital, Rennes, France.